Amneal Pharmaceuticals, Inc.
AMRX
$12.60
-$0.18-1.41%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 410.50% | 212.85% | 1,618.59% | 273.99% | 113.31% |
| Total Depreciation and Amortization | -28.21% | -25.56% | -8.29% | 8.17% | 8.34% |
| Total Amortization of Deferred Charges | -42.89% | -45.50% | -37.34% | -7.71% | 0.12% |
| Total Other Non-Cash Items | 55.97% | 0.42% | 234.80% | 7.91% | -6.11% |
| Change in Net Operating Assets | -78.68% | -156.23% | -218.64% | 38.10% | -788.42% |
| Cash from Operations | -461.00% | 10.36% | -16.45% | 111.36% | 267.98% |
| Capital Expenditure | 1.86% | -92.17% | 12.05% | -147.59% | -40.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -86.90% | -400.00% | -105.94% | -20.00% | 56.70% |
| Cash from Investing | -21.98% | -183.04% | -8.46% | -310.63% | 9.93% |
| Total Debt Issued | -37.99% | -- | -- | -- | 354.17% |
| Total Debt Repaid | 40.20% | 88.97% | -2,828.92% | 42.41% | -271.63% |
| Issuance of Common Stock | -44.93% | 266.23% | 5.83% | 91.34% | 146.43% |
| Repurchase of Common Stock | -104.75% | 17.05% | 33.51% | -18.87% | -200.04% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -13,325.00% | 7.55% | -1,466.74% | -221.33% | 88.55% |
| Cash from Financing | -50.78% | 83.47% | 164.37% | -18.81% | -69.15% |
| Foreign Exchange rate Adjustments | -117.66% | 71.76% | -10,014.29% | -203.96% | -184.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -116.95% | 85.98% | 438.71% | 865.81% | -5.34% |